Fmr LLC Bridge Bio Pharma, Inc. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,539,913 shares of BBIO stock, worth $41.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,539,913
Previous 2,325,612
33.78%
Holding current value
$41.7 Million
Previous $71.9 Million
45.76%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BBIO
# of Institutions
299Shares Held
178MCall Options Held
8.72MPut Options Held
2.75M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$841 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$681 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$381 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$337 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$164 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.02B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...